8Ganeval D,Rabian C,Guerin V,et al.Treatment of multiple myeloma with renal involment.Adv Nephrol Necker Hosp,1992,21:347-370.
9Sanchorawala V,Wright DG,Dember LM,et al.An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.Bone Marrow Transplant,2001,28(7):637-642.
10Alexanian R,Barlogie B,Dixon D.Renal failure in multiple myeloma.Pathogenisis and prognostic implication.Arch Intern Med,1990,150(8):1693-1695.
4Prakash J, Mandal AK, Vohra R,et al. Renal disease is a prodrome of multiple myeloma: an analysis of 50 patients from eastern India[J].Ren Fail, 2009, 31 (4): 267-271.
5Hernandez-Reyes J, Galo-Hooker E, Ruiz-Delgado GJ , et al.Systemic immunoglobulin light-chain amyloidosis (AL) in Mexico: a single institution, 30-year experience[J]. Rev Invest Clin, 2012, 64(6 Pt 2): 604-608.
6Gertz MA. Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment[J]. Am J Hematol, 2013, 88(5): 416-425.
7Tazawa K, Matsuda M, Yoshida T, et al. Therapeutic outcome of cyclic VAD (vincristine, doxorubicin and dexamethasone) therapy in primary systemic AL amyloidosis patients[J]. Intern Med, 2008, 47(17): 1517-1522.
8Suzuki K.Diagnosis and treatment of multiple myeloma and AL amyloidosis with focus on improvement of renal lesion[J]. Clin Exp Nephrol, 2012, 16(5): 659-671.
9Okuyama H, Yamaya H, Fukusima T, et al. A patient with persistent renal AL amyloid deposition after clinical remission by HDM/SCT therapy[J]. Clin Nephrol, 2013, 79(3): 233-236.
10Nasr SH, Valeri AM, Sethi S,et al.Clinicopathologic correlations in Multiple Myeloma. A case series of 190 patients with kidney biopsies[J]. Am J Kidney Dis, 2012, 59(6): 786-794.
